Mammalian milk allergy: case presentation and review of prevalence, diagnosis and treatment

Annals of Allergy, Asthma & Immunology

April 2017 Volume 118, Issue 4, Pages 406-410 MOC-CME Review

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee Members:
Michele Ngoc, Pham, MD (Author)
Julie Wang, MD (Author)
Jonathan A. Bernstein, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
Distinguish different types of mammalian milk allergy
Detect cross-reactivity in mammalian milk proteins
Evaluate nuances and difficulties of allergen avoidance in specific mammalian milk allergy

Additional information
Disclosure: 

J.A. Bernstein e PI, Consultant, Speaker for AstraZeneca, CSL Behring, Novartis/Genentech, and Shire, he received research grants and fees; Speaker for Baxalta, he received fees; Consultant for Imedics, he received fees; PI and Consultant for Boehringer Ingelheim and GlaxoSmithKline, he received research grants and fees. M.H. Grayson e Clinical research for Polyphor, Ltd., he received a research grant. G.D. Marshall e Clinical Research for Stallergens and Sanofi, he received research grants; J. Oppenheimer e Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for AstraZeneca, Boehringer Ingelheim, and Novartis, he received research grants. G. Krishnaswamy e Clinical Research for CSL Behring, he received a research grant. M. Ngoc Pham have no relevant financial relationships to disclose. Any unapproved/investigative uses of therapeutic agents/devices discussed are appropriately noted.
Recognition of Commercial Support: This activity has not received external commercial support.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
04/01/2017
Course expires: 
03/31/2019
Cost:
$0.00
Rating: 
0

Planning Committee Members:
Guha Krishnaswamy, MD (Author)
Sara Pasha, MD (Author)
Arjun B. Chatterjee, MD (Author)
Sandhya Kumar, MD (Author)
Anne K. Ellis, MD (Associate Editor)
Jonathan A. Bernstein, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
04/01/2017
Course expires: 
03/31/2019

Price

Cost:
$0.00
Please login or create an account to take this course.